A randomized phase II trial of interferon alpha-2A with and without 13-CIS retonoic acid [isotretinoin] in patients with progressive measurable metastatic renal cell carcinoma. Amendment Protocol: Extension to a Randomized Phase III Trial.
Phase of Trial: Phase III
Latest Information Update: 10 Jul 2012
At a glance
- Drugs Interferon alpha-2a (Primary) ; Interferon alpha; Isotretinoin
- Indications Renal cancer
- Focus Therapeutic Use
- 07 Sep 2005 New trial record.